{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T05:13:09Z","timestamp":1783660389105,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Biol"],"DOI":"10.1186\/s12915-026-02637-0","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T01:44:46Z","timestamp":1779155086000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrated genomics and transcriptomics reveal key events in pancreatic neuroendocrine neoplasm"],"prefix":"10.1186","volume":"24","author":[{"given":"Shiwei","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyi","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suizhi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yikai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beilei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiongfei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengli","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"issue":"2","key":"2637_CR1","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1210\/er.2018-00160","volume":"40","author":"A Mafficini","year":"2019","unstructured":"Mafficini A, Scarpa A. Genetics and epigenetics of gastroenteropancreatic neuroendocrine neoplasms. Endocr Rev. 2019;40(2):506\u201336.","journal-title":"Endocr Rev"},{"issue":"28","key":"2637_CR2","doi-asserted-by":"publisher","first-page":"4036","DOI":"10.3748\/wjg.v26.i28.4036","volume":"26","author":"GB Mpilla","year":"2020","unstructured":"Mpilla GB, Philip PA, El-Rayes B, Azmi AS. Pancreatic neuroendocrine tumors: therapeutic challenges and research limitations. World J Gastroenterol. 2020;26(28):4036\u201354.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"2637_CR3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41571-022-00696-0","volume":"20","author":"K Kawasaki","year":"2023","unstructured":"Kawasaki K, Rekhtman N, Quintanal-Villalonga \u00c1, Rudin CM. Neuroendocrine neoplasms of the lung and gastrointestinal system: convergent biology and a path to better therapies. Nat Rev Clin Oncol. 2023;20(1):16\u201332.","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"2637_CR4","doi-asserted-by":"publisher","first-page":"549","DOI":"10.2217\/fon-2020-0543","volume":"17","author":"L Lu","year":"2021","unstructured":"Lu L, Shang Y, Mullins CS, Zhang X, Linnebacher M. Epidemiologic trends and prognostic risk factors of patients with pancreatic neuroendocrine neoplasms in the US: an updated population-based study. Future Oncol. 2021;17(5):549\u201363.","journal-title":"Future Oncol"},{"issue":"10","key":"2637_CR5","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1097\/CM9.0000000000002643","volume":"136","author":"R Zheng","year":"2023","unstructured":"Zheng R, Zhao H, An L, Zhang S, Chen R, Wang S, et al. Incidence and survival of neuroendocrine neoplasms in China with comparison to the United States. Chin Med J (Engl). 2023;136(10):1216\u201324.","journal-title":"Chin Med J (Engl)"},{"issue":"11","key":"2637_CR6","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/s41416-019-0606-3","volume":"121","author":"TSE Genus","year":"2019","unstructured":"Genus TSE, Bouvier C, Wong KF, Srirajaskanthan R, Rous BA, Talbot DC, et al. Impact of neuroendocrine morphology on cancer outcomes and stage at diagnosis: a UK nationwide cohort study 2013\u20132015. Br J Cancer. 2019;121(11):966\u201372.","journal-title":"Br J Cancer"},{"key":"2637_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2019.101598","volume":"63","author":"D Wyld","year":"2019","unstructured":"Wyld D, Wan MH, Moore J, Dunn N, Youl P. Epidemiological trends of neuroendocrine tumours over three decades in Queensland, Australia. Cancer Epidemiol. 2019;63:101598.","journal-title":"Cancer Epidemiol"},{"issue":"9","key":"2637_CR8","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.24750","volume":"4","author":"Z Xu","year":"2021","unstructured":"Xu Z, Wang L, Dai S, Chen M, Li F, Sun J, et al. Epidemiologic trends of and factors associated with overall survival for patients with gastroenteropancreatic neuroendocrine tumors in the United States. JAMA Netw Open. 2021;4(9):e2124750.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"2637_CR9","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40164-020-00184-0","volume":"9","author":"H-L Gao","year":"2020","unstructured":"Gao H-L, Wang W-Q, Yu X-J, Liu L. Molecular drivers and cells of origin in pancreatic ductal adenocarcinoma and pancreatic neuroendocrine carcinoma. Exp Hematol Oncol. 2020;9(1):28.","journal-title":"Exp Hematol Oncol"},{"issue":"3","key":"2637_CR10","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1158\/2159-8290.CD-21-0669","volume":"12","author":"S Yachida","year":"2022","unstructured":"Yachida S, Totoki Y, No\u00eb M, Nakatani Y, Horie M, Kawasaki K, et al. Comprehensive Genomic Profiling of Neuroendocrine Carcinomas of the Gastrointestinal System. Cancer Discov. 2022;12(3):692\u2013711.","journal-title":"Cancer Discov"},{"issue":"2","key":"2637_CR11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s12022-024-09807-2","volume":"35","author":"S Uccella","year":"2024","unstructured":"Uccella S. Molecular classification of gastrointestinal and pancreatic neuroendocrine neoplasms: are we ready for that? Endocr Pathol. 2024;35(2):91\u2013106.","journal-title":"Endocr Pathol"},{"issue":"3","key":"2637_CR12","doi-asserted-by":"publisher","first-page":"302","DOI":"10.21037\/hbsn-21-413","volume":"12","author":"W Zhou","year":"2023","unstructured":"Zhou W, Han X, Ji Y, Wang D, Xie D, Qiu Z, et al. Targeted deep sequencing reveals the genetic heterogeneity in well-differentiated pancreatic neuroendocrine tumors with liver metastasis. Hepatobiliary Surg Nutr. 2023;12(3):302\u201313.","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"8","key":"2637_CR13","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1158\/1078-0432.CCR-19-2884","volume":"26","author":"AT Scott","year":"2020","unstructured":"Scott AT, Weitz M, Breheny PJ, Ear PH, Darbro B, Brown BJ, et al. Gene expression signatures identify novel therapeutics for metastatic pancreatic neuroendocrine tumors. Clin Cancer Res. 2020;26(8):2011\u201321.","journal-title":"Clin Cancer Res"},{"issue":"6021","key":"2637_CR14","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1126\/science.1200609","volume":"331","author":"Y Jiao","year":"2011","unstructured":"Jiao Y, Shi C, Edil BH, de Wilde RF, Klimstra DS, Maitra A, et al. DAXX\/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science. 2011;331(6021):1199\u2013203.","journal-title":"Science"},{"issue":"7643","key":"2637_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nature21063","volume":"543","author":"A Scarpa","year":"2017","unstructured":"Scarpa A, Chang DK, Nones K, Corbo V, Patch AM, Bailey P, et al. Whole-genome landscape of pancreatic neuroendocrine tumours. Nature. 2017;543(7643):65\u201371.","journal-title":"Nature"},{"issue":"5","key":"2637_CR16","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1136\/gutjnl-2018-317233","volume":"69","author":"X Hong","year":"2020","unstructured":"Hong X, Qiao S, Li F, Wang W, Jiang R, Wu H, et al. Whole-genome sequencing reveals distinct genetic bases for insulinomas and non-functional pancreatic neuroendocrine tumours: leading to a new classification system. Gut. 2020;69(5):877\u201387.","journal-title":"Gut"},{"issue":"7","key":"2637_CR17","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1210\/jc.2017-02646","volume":"103","author":"A Tamura","year":"2018","unstructured":"Tamura A, Ogasawara T, Fujii Y, Kaneko H, Nakayama A, Higuchi S, et al. Glucagonoma With Necrolytic Migratory Erythema: Metabolic Profile and Detection of Biallelic Inactivation of DAXX Gene. J Clin Endocrinol Metab. 2018;103(7):2417\u201323.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2637_CR18","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1210\/endrev\/bnad034","volume":"45","author":"AP Webster","year":"2024","unstructured":"Webster AP, Thirlwell C. The molecular biology of midgut neuroendocrine neoplasms. Endocr Rev. 2024;45(3):343\u201350.","journal-title":"Endocr Rev"},{"issue":"15","key":"2637_CR19","doi-asserted-by":"publisher","first-page":"3296","DOI":"10.1158\/1078-0432.CCR-21-4165","volume":"28","author":"TT Sepp\u00e4l\u00e4","year":"2022","unstructured":"Sepp\u00e4l\u00e4 TT, Zimmerman JW, Suri R, Zlomke H, Ivey GD, Szabolcs A, et al. Precision Medicine in Pancreatic Cancer: Patient-Derived Organoid Pharmacotyping Is a Predictive Biomarker of Clinical Treatment Response. Clin Cancer Res. 2022;28(15):3296\u2013307.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"2637_CR20","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.tig.2016.07.002","volume":"32","author":"G Macintyre","year":"2016","unstructured":"Macintyre G, Ylstra B, Brenton JD. Sequencing structural variants in cancer for precision therapeutics. Trends Genet. 2016;32(9):530\u201342.","journal-title":"Trends Genet"},{"issue":"7605","key":"2637_CR21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature17676","volume":"534","author":"S Nik-Zainal","year":"2016","unstructured":"Nik-Zainal S, Davies H, Staaf J, Ramakrishna M, Glodzik D, Zou X, et al. Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature. 2016;534(7605):47\u201354.","journal-title":"Nature"},{"issue":"1","key":"2637_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1469-4","volume":"38","author":"WJ Bae","year":"2019","unstructured":"Bae WJ, Ahn JM, Byeon HE, Kim S, Lee D. PTPRD-inactivation-induced CXCL8 promotes angiogenesis and metastasis in gastric cancer and is inhibited by metformin. J Exp Clin Cancer Res. 2019;38(1):484.","journal-title":"J Exp Clin Cancer Res"},{"issue":"17","key":"2637_CR23","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1038\/s41388-021-01768-8","volume":"40","author":"Y Lin","year":"2021","unstructured":"Lin Y, Zhou X, Yang K, Chen Y, Wang L, Luo W, et al. Protein tyrosine phosphatase receptor type D gene promotes radiosensitivity via STAT3 dephosphorylation in nasopharyngeal carcinoma. Oncogene. 2021;40(17):3101\u201317.","journal-title":"Oncogene"},{"issue":"1","key":"2637_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14614-4","volume":"11","author":"H Qiu","year":"2020","unstructured":"Qiu H, Jin B-M, Wang Z-F, Xu B, Zheng Q-F, Zhang L, et al. MEN1 deficiency leads to neuroendocrine differentiation of lung cancer and disrupts the DNA damage response. Nat Commun. 2020;11(1):1009.","journal-title":"Nat Commun"},{"issue":"1","key":"2637_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-75882-4","volume":"14","author":"Z Chen","year":"2024","unstructured":"Chen Z, Lin S, Liang F, Hou Z, Yang Y, Huang H, et al. The prognostic and therapeutic value of the tumor microenvironment and immune checkpoints in pancreatic neuroendocrine neoplasms. Sci Rep. 2024;14(1):24669.","journal-title":"Sci Rep"},{"issue":"9","key":"2637_CR26","doi-asserted-by":"publisher","first-page":"8653","DOI":"10.3390\/curroncol30090627","volume":"30","author":"J Kaur","year":"2023","unstructured":"Kaur J, Vijayvergia N. Narrative review of immunotherapy in gastroentero-pancreatic neuroendocrine neoplasms. Curr Oncol. 2023;30(9):8653\u201364.","journal-title":"Curr Oncol"},{"issue":"6","key":"2637_CR27","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.ccell.2021.04.014","volume":"39","author":"A Bagaev","year":"2021","unstructured":"Bagaev A, Kotlov N, Nomie K, Svekolkin V, Gafurov A, Isaeva O, et al. Conserved pan-cancer microenvironment subtypes predict response to immunotherapy. Cancer Cell. 2021;39(6):845-65.e7.","journal-title":"Cancer Cell"},{"key":"2637_CR28","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar3593","author":"R Cristescu","year":"2018","unstructured":"Cristescu R, Mogg R, Ayers M, Albright A, Murphy E, Yearley J, et al. Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy. Science. 2018. https:\/\/doi.org\/10.1126\/science.aar3593.","journal-title":"Science"},{"issue":"10","key":"2637_CR29","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1136\/gutjnl-2020-321016","volume":"70","author":"K Young","year":"2021","unstructured":"Young K, Lawlor RT, Ragulan C, Patil Y, Mafficini A, Bersani S, et al. Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours. Gut. 2021;70(10):1904.","journal-title":"Gut"},{"issue":"1","key":"2637_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24812-3","volume":"12","author":"J van Riet","year":"2021","unstructured":"van Riet J, van de Werken HJG, Cuppen E, Eskens FALM, Tesselaar M, van Veenendaal LM, et al. The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets. Nat Commun. 2021;12(1):4612.","journal-title":"Nat Commun"},{"key":"2637_CR31","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.161370","author":"M Zhou","year":"2022","unstructured":"Zhou M, Ko M, Hoge AC, Luu K, Liu Y, Russell ML, et al. Patterns of structural variation define prostate cancer across disease states. JCI Insight. 2022. https:\/\/doi.org\/10.1172\/jci.insight.161370.","journal-title":"JCI Insight"},{"issue":"2","key":"2637_CR32","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1182\/blood-2005-05-2093","volume":"107","author":"C Mayr","year":"2006","unstructured":"Mayr C, Speicher MR, Kofler DM, Buhmann R, Strehl J, Busch R, et al. Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia. Blood. 2006;107(2):742\u201351.","journal-title":"Blood"},{"issue":"18","key":"2637_CR33","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.21037\/atm-20-4733","volume":"8","author":"X Huang","year":"2020","unstructured":"Huang X, Qin F, Meng Q, Dong M. Protein tyrosine phosphatase receptor type D (PTPRD)-mediated signaling pathways for the potential treatment of hepatocellular carcinoma: a narrative review. Ann Transl Med. 2020;8(18):1192.","journal-title":"Ann Transl Med"},{"issue":"6","key":"2637_CR34","doi-asserted-by":"publisher","first-page":"5361","DOI":"10.3934\/mbe.2022251","volume":"19","author":"C Ou","year":"2022","unstructured":"Ou C, Peng Q, Zeng C. An integrative prognostic and immune analysis of PTPRD in cancer. Math Biosci Eng. 2022;19(6):5361\u201379.","journal-title":"Math Biosci Eng"},{"issue":"13","key":"2637_CR35","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1158\/0008-5472.CAN-22-3599","volume":"83","author":"J Xu","year":"2023","unstructured":"Xu J, Ye Z, Zhuo Q, Gao H, Qin Y, Lou X, et al. MEN1 degradation induced by neddylation and the CUL4B\u2013DCAF7 axis promotes pancreatic neuroendocrine tumor progression. Cancer Res. 2023;83(13):2226\u201347.","journal-title":"Cancer Res"},{"issue":"35","key":"2637_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202308417","volume":"11","author":"J Xu","year":"2024","unstructured":"Xu J, Lou X, Wang F, Zhang W, Xu X, Ye Z, et al. MEN1 Deficiency-Driven Activation of the \u03b2-Catenin-MGMT Axis Promotes Pancreatic Neuroendocrine Tumor Growth and Confers Temozolomide Resistance. Adv Sci (Weinh). 2024;11(35):e2308417.","journal-title":"Adv Sci (Weinh)"},{"issue":"10","key":"2637_CR37","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1158\/2159-8290.CD-23-1249","volume":"14","author":"TM Baker","year":"2024","unstructured":"Baker TM, Lai S, Lynch AR, Lesluyes T, Yan H, Ogilvie HA, et al. The History of Chromosomal Instability in Genome-Doubled Tumors. Cancer Discov. 2024;14(10):1810\u201322.","journal-title":"Cancer Discov"},{"issue":"7846","key":"2637_CR38","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41586-020-03133-3","volume":"590","author":"RJ Quinton","year":"2021","unstructured":"Quinton RJ, DiDomizio A, Vittoria MA, Kot\u00fdnkov\u00e1 K, Ticas CJ, Patel S, et al. Whole-genome doubling confers unique genetic vulnerabilities on tumour cells. Nature. 2021;590(7846):492\u20137.","journal-title":"Nature"},{"issue":"8","key":"2637_CR39","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1038\/s41588-018-0165-1","volume":"50","author":"CM Bielski","year":"2018","unstructured":"Bielski CM, Zehir A, Penson AV, Donoghue MTA, Chatila W, Armenia J, et al. Genome doubling shapes the evolution and prognosis of advanced cancers. Nat Genet. 2018;50(8):1189\u201395.","journal-title":"Nat Genet"},{"issue":"1","key":"2637_CR40","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.celrep.2012.12.008","volume":"3","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov LB, Nik-Zainal S, Wedge DC, Campbell PJ, Stratton MR. Deciphering signatures of mutational processes operative in human cancer. Cell Rep. 2013;3(1):246\u201359.","journal-title":"Cell Rep"},{"issue":"3","key":"2637_CR41","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41588-019-0576-7","volume":"52","author":"I Cort\u00e9s-Ciriano","year":"2020","unstructured":"Cort\u00e9s-Ciriano I, Lee JJ, Xi R, Jain D, Jung YL, Yang L, et al. Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing. Nat Genet. 2020;52(3):331\u201341.","journal-title":"Nat Genet"},{"issue":"3","key":"2637_CR42","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.cell.2013.03.021","volume":"153","author":"SC Baca","year":"2013","unstructured":"Baca SC, Prandi D, Lawrence MS, Mosquera JM, Romanel A, Drier Y, et al. Punctuated evolution of prostate cancer genomes. Cell. 2013;153(3):666\u201377.","journal-title":"Cell"},{"issue":"12","key":"2637_CR43","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1158\/2159-8290.CD-15-0068","volume":"5","author":"A Sadanandam","year":"2015","unstructured":"Sadanandam A, Wullschleger S, Lyssiotis CA, Grotzinger C, Barbi S, Bersani S, et al. A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics. Cancer Discov. 2015;5(12):1296\u2013313.","journal-title":"Cancer Discov"},{"issue":"1","key":"2637_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06498-2","volume":"9","author":"CS Chan","year":"2018","unstructured":"Chan CS, Laddha SV, Lewis PW, Koletsky MS, Robzyk K, Da Silva E, et al. ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup. Nat Commun. 2018;9(1):4158.","journal-title":"Nat Commun"},{"key":"2637_CR45","unstructured":"Jin G. Integrated profiling of pancreatic neuroendocrine neoplasms. NGDC Accession: HDAC002913 (https:\/\/ngdc.cncb.ac.cn\/gsa-human\/browse\/HRA005953), 2025."}],"container-title":["BMC Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12915-026-02637-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12915-026-02637-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12915-026-02637-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T04:19:32Z","timestamp":1783657172000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12915-026-02637-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2637"],"URL":"https:\/\/doi.org\/10.1186\/s12915-026-02637-0","relation":{},"ISSN":["1741-7007"],"issn-type":[{"value":"1741-7007","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"28 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the national guidelines and was approved by the Ethics Committee of Changhai Hospital (Approval number: CHEC2017-147). Written informed consent was obtained from all patients for the utilization of their clinical data and surgical specimens. In addition to approval by the local institutional review board, this study was reviewed by and is compliant with the Chinese Ministry of Science and Technology (MOST) for the Review and Approval of Human Genetic Resources.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"162"}}